Investors & Media

Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and key figures.

Latest News

Medigene presented preclinical data on its PRAME-specific TCR at AACR conference

SHOW RELEASE

Academic partner presented compassionate use data on AML DC vaccine at AACR conference

SHOW RELEASE

PTA-NVR: Medigene AG: Total Voting Rights Announcement according to Article 26a of the WpHG

SHOW RELEASE

The Medigene Share

The Medigene share MDG1 (ISIN:DE000A1X3W00 ) is listed at the Frankfurt Stock Exchange since June 2000. The share is part of TecDAX, an index of the Deutsche Börse (German Stock Exchange) that includes Germany's most important mid-cap technology companies.

show medigene share

Events

24 - 26 Apr 2017

European Neoantigen Summit 2017

Amsterdam, Netherlands

11 May 2017

3-Months Report

24 May 2017

Annual General Meeting 2017

03 Aug 2017

6-Months Report

09 Nov 2017

9-Months Report

Reports & Presentations

2016

Presentation webcast

2016

Annual Report 2016

2016

Medigene corporate presentation

Annual General Meeting 2017

The Annual General Meeting of Medigene shareholders for fiscal year 2016 will be held in German language on Wednesday, 24 May 2017 at the Conference Center Munich of the Hanns-Seidel-Stiftung in Munich (Lazarettstr. 33, 80636 Munich). 

read more

Corporate Governance

Good corporate governance is the basis of our decision-making and monitoring processes. It stands for responsible and value-based leadership and control of the Company for long-term success, goal-oriented and efficient cooperation between the Executive Board and Supervisory Board, respect for the interests of our shareholders and employees, consistently transparent and responsible corporate decisions and an appropriate risk management system.

read more

press photos

Laboratory work (1)

HPLC loading with samples

DownLoad (2 MB)

Laboratory work (2)

Weighing of a substance

DownLoad (8 MB)

Laboratory work (3)

Sampling from a nitrogen tank

DownLoad (9 MB)

Contact person

Julia Hofmann
Senior Director, Head of Public & Investor Relations
investor(at)medigene.com
public.relations(at)medigene.com
Telefon: +49-89-20 00 33-33 01
Fax: +49-89-20 00 33-29 20

Dr. Robert Mayer
Senior Manager Public & Investor Relations
investor(at)medigene.com
public.relations(at)medigene.com
Telefon: +49-89-20 00 33-33 01
Fax: +49-89-20 00 33-29 20